PPARG and neoplasm: Studies have shown that PPAR-γ agonists have obvious antitumor effects and their mechanisms include inhibiting cell proliferation, promoting cell apoptosis and differentiation, inhibiting angiogenesis, and reducing tumor invasiveness.